Biomarkers in Drug Discovery & Development
|Event Date/Time: Jun 11, 2012|
To answer the challenges connected with utilization of biomarkers, we bring together the pharmaceutical minds along with representatives from academia, research institutions and non-profit organizations.
Two focused conference days offer case studies exploiting the best practices in accelerating the identification of biomarkers, cutting the costs of attrition of compounds, reducing the size, cost and duration of clinical trials as well as the possibility of adverse events.
REASONS TO ATTEND
Exploit the latest technologies for biomarker identification
Understand how to discover robust biomarkers for pharmacodynamic and predictive purposes
Gain knowledge about biomarkers utilisation for breast cancer therapy decisions in clinical trials
Learn about contribution of imaging to decision-making in drug
Hear case studies about successful application of biomarkers in various therapeutic areas â€“ moving towards a personalized medicine approach
WHO WILL YOU MEET
Senior Vice Presidents, Chief Scientific Officers, Vice Presidents, Heads, Directors, Scientists, Researchers, Investigators, Professors in:
Biomarkers, Clinical Research, Drug Discovery and Development, Translational Research/ Science/ Imaging, Molecular Imaging, Experimental Medicine, Clinical Pharmacology, Molecular Toxicology, â€œOmicsâ€ Programmes, Clinical Discovery Technologies, Diagnostics, Biomarker Strategy, Assay Development, Pathway Analysis, Regulatory Affairs, etc.